Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 367.90 INR
Change Today +5.90 / 1.63%
Volume 44.6K
SAPH On Other Exchanges
Symbol
Exchange
Natl India
As of 12:30 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

shasun pharmaceuticals ltd (SAPH) Snapshot

Open
374.00
Previous Close
362.00
Day High
374.00
Day Low
362.60
52 Week High
08/20/15 - 415.95
52 Week Low
10/7/14 - 175.00
Market Cap
24.7B
Average Volume 10 Days
322.8K
EPS TTM
3.93
Shares Outstanding
67.2M
EX-Date
08/4/15
P/E TM
93.6x
Dividend
1.00
Dividend Yield
0.27%
Current Stock Chart for SHASUN PHARMACEUTICALS LTD (SAPH)

Related News

No related news articles were found.

shasun pharmaceuticals ltd (SAPH) Related Businessweek News

No Related Businessweek News Found

shasun pharmaceuticals ltd (SAPH) Details

Shasun Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and formulations to the pharmaceutical industry primarily in India. The company offers API products in the areas of pain management and musculoskeletal, central nervous system, cardiovascular, hyperphosphataemia, COPD, anti-infective, gastrointestinal, gastrointestinal, cough suppressants, and anti-emetic. It also engages in the contract research and manufacturing services business, which provides chemistry and analytical services; and offers formulation development and manufacturing services for solid dosage products to pharmaceutical customers. In addition, it offers enteric coating excipients and generic products. The company also exports its products to North America, Europe, rest of Asia, and Latin America. The company was formerly known as Shasun Chemicals and Drugs Ltd. Shasun Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Chennai, India.

Founded in 1976

shasun pharmaceuticals ltd (SAPH) Top Compensated Officers

Chief Executive Officer, Managing Director, W...
Total Annual Compensation: 13.0M
Chief Financial Officer
Total Annual Compensation: 8.6M
Director of Operations & EHS and Whole Time D...
Total Annual Compensation: 3.6M
Wholetime Director
Total Annual Compensation: 8.6M
Whole-Time Director and Member of Corporate S...
Total Annual Compensation: 8.6M
Compensation as of Fiscal Year 2015.

shasun pharmaceuticals ltd (SAPH) Key Developments

Shasun Pharmaceuticals Ltd Declares Interim Dividend

Shasun Pharmaceuticals Ltd. announced that the board of directors of the company at its meeting held on July 30, 2015, has approved the interim dividend of 50% (INR 1 per share) on the equity shares of face value of INR 2 each.

Shasun Pharmaceuticals Ltd. Announces Unaudited Standalone and Consolidated Earnings Results for the First Quarter Ended June 30, 2015

Shasun Pharmaceuticals Ltd. announced unaudited standalone and consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the standalone company reported net sales of INR 2,455.5 million against INR 2,369.8 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 161.5 million against INR 113.7 million a year ago. Profit from ordinary activities before tax was INR 77.2 million against INR 36.6 million a year ago. Net profit was INR 69.9 million against INR 36.6 million a year ago. Diluted earnings per share before and after extraordinary items were INR 1.10 against INR 0.63 a year ago. For the quarter, the consolidated company reported net sales of INR 3,191.7 million against INR 2,997.7 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 162.6 million against INR 46.6 million a year ago. Profit from ordinary activities before tax was INR 49.9 million against loss of INR 50.1 million a year ago. Net profit was INR 38.0 million against loss of INR 47.9 million a year ago. Diluted earnings per share before and after extraordinary items were INR 0.60 against loss of INR 0.83 a year ago. EBITDA of INR 383 million against INR 208 million a year ago.

Shasun Pharmaceuticals Ltd to Report Q1, 2016 Results on Jul 30, 2015

Shasun Pharmaceuticals Ltd announced that they will report Q1, 2016 results on Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAPH:IN 367.90 INR +5.90

SAPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aurobindo Pharma Ltd 735.80 INR -1.95
Cipla Ltd/India 658.00 INR -5.15
Dishman Pharmaceuticals & Chemicals Ltd 237.95 INR +12.55
Jubilant Life Sciences Ltd 358.00 INR +7.75
Piramal Enterprises Ltd 932.10 INR -4.55
View Industry Companies
 

Industry Analysis

SAPH

Industry Average

Valuation SAPH Industry Range
Price/Earnings 67.4x
Price/Sales 1.6x
Price/Book 5.5x
Price/Cash Flow 28.8x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHASUN PHARMACEUTICALS LTD, please visit www.shasun.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.